netFormulary NHS
Herefordshire & Worcestershire
Medicines and Prescribing Committee
 Search
 Formulary Chapter 3: Respiratory system - Full Chapter
Notes:
Osmohale as been approved as a standardised BHR challenge test in secondary care in line with the product's marketing authorisation in the Summary of Product Characteristics (SPC)
Chapter Links...
 Details...
03.01.04  Expand sub section  Compound bronchodilator preparations
Aclidinium & formoterol  (Duaklir® Genuair)
View adult BNF View SPC online View childrens BNF
Formulary
Green

Approved for the maintenance treatment of COPD; to be considered as a twice daily LAMA/LABA option when initiating treatment for a new patient.


PRESCRIBE BY BRAND 

 
 
Glycopyrronium & indacaterol
(Ultibro® Breezhaler.)
View adult BNF View SPC online View childrens BNF
Formulary
Green

Approved for  the maintenance treatment of COPD; to be considered as a once daily LAMA/LABA option when initiating treatment for a new patient


PRESCRIBE BY BRAND

 
 
Tiotropium & olodaterol (Spiolto® Respimat)
View adult BNF View SPC online View childrens BNF
Formulary
Green

 LAMA/LABA option for COPD  patients unable to use dry powder inhalers


 PRESCRIBE BY BRAND

 
 
Umeclidinium & vilanterol  (Anoro® Ellipta.)
View adult BNF View SPC online View childrens BNF
Formulary
Green

Approved for the maintenance treatment of COPD; to be considered as a once daily LAMA/LABA option when initiating treatment for a new patient.


PRESCRIBE BY BRAND

 
 
Ipratropium bromide & salbutamol (Combivent® Nebules)
View adult BNF View SPC online View childrens BNF
Formulary
Green
 
 
 ....
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

Red

Secondary care only, not to be prescribed in primary care.   

Amber with Shared Care

Specialist initiation with shared care guidance Medicines which should be initiated in secondary care by the specialist with follow-on prescription and monitoring according to a specific Shared Care (SC) Guideline. Prescribing may be continued in primary care in line with a shared care guideline   

Amber

Considered suitable for primary care prescribing following specialist initiation/recommendation.  

Green

Considered appropriate for prescribing in both secondary and primary care. Suitable for initiation in primary care.   

netFormulary